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ABSTRACT 
Coronary 18F-sodium fluoride (18F-NaF) PET imaging identifies ruptured plaques in patients 
with recent myocardial infarction and localizes to atherosclerotic lesions with active 
calcification. Most studies to date performed the PET acquisition 1-hour (1h) post-injection. 
Although qualitative and semi-quantitative analysis is feasible with 1h images, often residual 
blood pool activity makes it difficult to discriminate plaques with 18F-NaF uptake from noise. 
We aimed to assess whether delayed 3-hour (3h) post-injection PET scan improves image quality 
and uptake measurements.  
Methods 
Twenty patients (67±7years old, 55% male) with stable coronary artery disease underwent 
coronary CT angiography and PET/CT both 1 h and 3 h after the injection of 266.2±13.3 MBq of 
18F-NaF. We compared the visual pattern of coronary uptake, maximal background (blood pool) 
activity, noise, standard uptake values (SUVmax), corrected SUV (cSUVmax) and target to 
background (TBR) measurements in lesions defined by CTA on 1h vs 3h post injection 18F-NaF 
PET.    
Results 
On 1h PET 26 CTA lesions with 18F-NaF PET uptake were identified in 12 (60%) patients.  On 
3h PET we detected 18F-NaF PET uptake in 7 lesions which were not identified on the 1h PET. 
The median cSUVmax and TBR values of these lesions were 0.48 [interquartile range (IQR) 
0.44-0.51] and 1.45 [IQR, 1.39-1.52] compared to -0.01 [IQR, -0.03-0.001] and 0.95 [IQR, 0.90-
0.98] on 1h PET, both p<0.001. Across the entire cohort 3h PET SUVmax values were similar to 
1h PET measurements 1.63 [IQR, 1.37-1.98] vs. 1.55 [IQR, 1.43-1.89], p=0.30 and the 
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background activity was lower 0.71 [IQR, 0.65-0.81] vs. 1.24 [IQR, 1.05-1.31], p<0.001. On 3h 
PET, the TBR values, cSUVmax and the noise were significantly higher (2.30 [IQR, 1.70-2.68] 
vs 1.28 [IQR, 0.98-1.56], p<0.001; 0.38 [IQR, 0.27-0.70] vs 0.90 [IQR, 0.64-1.17], p<0.001 and 
0.10 [IQR, 0.09-0.12] vs. 0.07 [IQR, 0.06-0.09], p=0.02). The median cSUVmax and TBR 
values increased by 92% (range: 33-225%) and 80% (range: 20-177%). 
 
Conclusions 
Blood-pool activity decreases on delayed imaging facilitating the assessment of 18F-NaF uptake 
in coronary plaques. The median target to background ratios increase by 80% leading to the 
detection of more plaques with significant uptake compared to the standard 1h protocol. A 
greater than a 1h delay may improve the detection of 18F-NaF uptake in coronary artery plaques. 
Keywords  
PET/CT 
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Coronary artery disease 
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Introduction 
Coronary 18F-sodium fluoride (18F-NaF) PET imaging depicts biological processes involved in 
plaque formation and rupture in patients with coronary artery disease (1). Increased 18F-NaF 
uptake has been observed with hybrid PET (positron emission tomography)/coronary CT 
angiography (CTA) to localize in regions of recent plaque rupture in patients with acute 
myocardial infarction as well as in coronary plaques with high-risk features on intravascular 
ultrasound in patients with stable coronary artery disease (CAD) (2). As this promising imaging 
approach is still in its infancy, several technical aspects regarding 18F-NaF coronary PET 
imaging remain to be addressed (3,4).   
In the 1970s when 18F-NaF was first used for bone scanning, Blau et al suggested that the 
optimal scanning time for 18F-NaF is 2-4 hours post injection (5,6). Nevertheless, whole-body 
18F-NaF PET is nowadays most often performed with imaging commencing 60 minutes after 
injection (7-10). In cardiovascular PET, in most studies to date assessing 18F-NaF uptake in 
atherosclerotic plaques, acquisition was performed 1-hour (1h) after tracer administration 
(1,2,11-13). Although semi-quantitative analysis is feasible with 1h images, it can be difficult to 
discriminate plaques with 18F-NaF uptake from noise. Recently, it has been speculated that the 
optimal time for atherosclerotic plaque imaging with 18F-sodium fluoride might differ from the 
1h post injection time-point used for bone imaging (13). Up to date only one study looked at the 
optimal timing for cardiovascular 18F-NaF imaging, but performed the ungated low-count PET 
acquisition measuring overall uptake in the entire heart rather than in coronary plaques (14).  In 
this study, we aimed to quantitatively assess whether delayed 3-hour (3h) post-injection state-of-
the-art PET scanning improves image quality and coronary 18F-NaF uptake measurements.  
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Materials and Methods 
Patients 
We analyzed scans of 20 patients with stable coronary artery disease who underwent coronary 
CTA and PET/CT imaging both 1h and 3h after a single injection of 18F-NaF at Severance 
Cardiovascular Hospital.  All study participants had angiographically proven CAD (defined as at 
least one >50% luminal stenosis). Exclusion criteria included, renal dysfunction (eGFR ≤30 
mL/min/1.73 m2), contraindication to iodinated contrast agents, significant ventricular or atrial 
arrhythmia (which could compromise image quality), class III congestive heart failure and 
ejection fraction <35%. The study was approved by the investigational review board, and written 
informed consent was obtained from all enrolled patients.  
Imaging acquisition and reconstruction 
PET 
All patients underwent 18F-NaF PET/CT on a hybrid PET-CT scanner (Discovery 710, GE 
Healthcare, Milwaukee, WI, USA). Prior to imaging, subjects were administered with a target 
dose of 250 MBq of 18F-NaF and rested in a quiet environment for 60 minutes. After the 
acquisition of a non-contrast attenuation correction scan, PET data was acquired in list mode for 
30 minutes. The list mode dataset was reconstructed using a standard ordered expectation 
maximization algorithm with resolution recovery (SharpIR). Corrections were applied for 
attenuation, dead time, scatter and random coincidences. Utilizing 10 cardiac gates, the data were 
reconstructed on a 256x256 matrix (20x20cm field of view) using 24 subsets and applying 4 
iterations along with 5mm Gaussian smoothing. For standard uptake value (SUV) assessment, all 
analyzed values were decay-corrected to the injection time. 
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CT angiography 
After the 1h PET acquisition, contrast-enhanced coronary CTA was performed with prospective 
ECG-triggering if the heart rate was <60 beats/min and regular or with ECG gated helical 
acquisition if the heart rate >60 beats/min or irregular. All patients received beta blockers and 
sublingual nitrates. For contrast-enhanced imaging iodinated contrast (65-130ml) was power 
injected at 5-6 ml/sec, followed by a saline flush. Transverse images were reconstructed using 
filtered back projection with 0.65-mm slice thickness, 0.4 mm increment, and a medium-soft 
convolution kernel.  
Delayed PET 
A second low-dose CT for attenuation correction and PET was performed 3h after tracer 
administration using the same protocol for imaging and the same reconstruction of PET datasets 
as used in the 1h study.  
PET Motion correction 
Cardiac motion correction was performed on the 1h and 3h 18F-NaF PET/CT data. This 
technique compensates for coronary artery motion by aligning all gates to the end-diastolic 
position and has demonstrated its ability to reduce image noise and improve target to background 
ratio (TBR) (15). First, anatomic coronary artery data was extracted from diastolic coronary 
CTA by applying a vessel tracking algorithm based on Bayesian maximal paths using dedicated 
software (Autoplaque version 2.0, Cedars-Sinai Medical Center). Second, a diffeomorphic mass-
preserving image registration algorithm was used to align the 10 gates of PET data to the end-
diastolic gate (gate 7 or 8 dependent on the timing of the CTA acquisition). After motion 
correction, the 10 gates were summed to build a motion-free image containing counts from the 
entire PET acquisition. 
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Image analysis 
Coronary CTA 
Evaluation of coronary artery plaques was conducted in accordance with the Society of 
Cardiovascular Computed Tomography guidelines (16). The extent of disease was characterized 
by lesion maximal stenosis (Autoplaque version 2.0, Cedars-Sinai Medical Center), plaque 
composition (non-calcified/partially calcified/totally calcified), the segment involvement score 
(SIS) and coronary calcium scoring (17,18). 
PET 
Coronary 18F-NaF image analysis was performed on axial images using FusionQuant Software 
(Cedars Sinai Medical Center, Los Angeles). PET and CTA reconstructions were reoriented, 
fused and systematically co-registered in all 3 planes. Key points of reference were the sternum, 
vertebrae, blood pool in the ventricles and the great vessels. For each scan, plaque activity was 
measured by delimiting 3-dimensional volumes of interest on lesions. All segments with 
coronary plaque (at least a grade 2 stenosis [>25%]) and a lumen diameter ≥2 mm, as defined by 
CTA were interrogated. The maximum standard uptake value (SUVmax) was recorded from all 
these segments by delimiting a spherical volume of interest (radius=5mm). Background blood 
pool activity (SUVmean) was measured by delimiting a cylindrical volume of interest 
(radius=10mm, thickness = 5mm) in the right atrium on the level of the right coronary artery 
orifice (19). TBRs were calculated by dividing SUVmax by averaged background blood pool 
activity. Corrected maximum standard uptake values (cSUVmax) were calculated by subtracting 
the blood-pool activity from SUVmax. Image noise was defined as the coefficient of variance of 
the blood pool activity. Coronary plaques were considered clearly positive for 18F-NaF uptake if 
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they presented with focal tracer uptake arising from the coronary plaque which followed the 
course of the vessel in three dimensions over more than one slice and had a TBR>1.25 (2). In 
addition to reporting decay corrected uptake values we also evaluated the raw counts. The PET 
acquisitions were analyzed independently with at least a 21-day interval between the reading of 
the 1h and the 3h after injection scan.  
 
Statistical Analysis 
Continuous data are expressed as mean (standard deviation) or median [interquartile range 
(IQR)] as appropriate. Parametric data were compared using student’s T-test and paired student’s 
T-test, non-parametric data were compared using Wilcoxon rank sum and Wilcoxon signed-rank 
test where appropriate. Categorical variables are presented as absolute numbers (percentage) and 
were compared using a Chi-squared test or Fisher’s exact test where appropriate. A two-sided p 
value <0.05 was considered statistically significant. Statistical analyses were performed using 
SPSS (version 24, IBM, USA) software. 
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Results 
Twenty patients (67±7 years old, 55% male) were recruited into the study. Patient baseline 
characteristics are shown in Table 1. On CTA, the median segment involvement and coronary 
calcium scores were 6 [IQR, 3-8] and 413 [IQR, 50-770] respectively. Exact PET tracer injected 
doses were 266.2±13.3 MBq of 18F-NaF. 
1h post injection imaging 
On 1h PET (acquisition 66.5 [IQR, 64.5-71.8] min post injection), coronary uptake exceeding the 
TBR=1.25 threshold was observed in 12 (60%) patients. Twenty-six CTA segments were 
considered positive for 18F-NaF uptake. Eleven (41%) were in the left anterior descending, 6 
(23%) in the left circumflex, 4 (16%) in the left main and 5 (20%) in the right coronary artery. 
The association between patients’ baseline characteristics, risk-profiles and CTA findings are 
presented in supplementary Tables S1 and S2.   
3h post injection imaging 
On delayed PET imaging (acquisition 180.5 [IQR, 177.3-193.0] min post injection), by visual 
inspection background 18F-NaF activity was markedly reduced, and coronary lesions were more 
conspicuous. We identified all segments which were detected on 1h post injection imaging 
(Figure 1). In addition, 7 new segments (median stenosis 48.6% [IQR, 35.7-60.2]) which were 
previously negative for 18F-NaF uptake demonstrated focal uptake with TBR>1.25 (Figure 2). 
These lesions were found in 2 patients who had uptake elsewhere in the coronary vasculature and 
in 3 patients classified as negative for 18F-NaF coronary uptake on 1h post injection imaging. 
While the SUVmax of these 7 new positive lesions was similar on 3h vs 1h PET (1.51 [IQR, 
1.42-1.60] vs. 1.48 [IQR, 1.40-1.55], p=0.68), the cSUVmax and TBR values were higher on 
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delayed imaging (0.48 [IQR, 0.44-0.51] vs. -0.01 [IQR, -0.03-0.001] and 1.45 [IQR, 1.39-1.52] 
vs. 0.95 [IQR, 0.90-0.98], both p<0.001). 
Across the entire cohort on 3h PET compared to 1h PET, the SUVmax of the detected lesions 
remained similar (1.63 [IQR, 1.37-1.98] vs. 1.55 [IQR, 1.43-1.89], p=0.30). However, the 
background activity decreased to 0.71 [IQR, 0.65-0.81] vs. 1.24 [IQR, 1.05-1.31], p<0.001 with 
a median decrease of 42% (range 18-48%).  Consequently, the TBR values were higher (2.30 
[IQR, 1.70-2.68] vs 1.28 [IQR, 0.98-1.56], p<0.001), with a median TBR increase of 80% 
(range: 20-177%, Figures: 3 and 4). A similar change was observed in the cSUVmax 0.38 [IQR, 
0.27-0.70] vs 0.90 [IQR, 0.64-1.17], p<0.001; median cSUVmax increased by 92% (range: 33-
225%, Figures 3 and 4). In accordance with the Poisson’s distribution, we observed a 49.0±3.8% 
decrease in counts on delayed imaging compared to 1h PET. As expected due to fewer counts on 
3h PET, noise increased 0.10 [IQR, 0.09-0.12] vs. 0.07 [IQR, 0.06-0.09], p=0.02. 
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Discussion 
This is the first study which utilized a 30min acquisition cardiac-gated coronary PET protocol 
and compared the image quality and quantitative measures of 18F-NaF coronary uptake on 1h vs 
3h post injection PET images. We hereby show that prolonging the time from tracer injection to 
PET acquisition can facilitate image analysis and provide lower background activity, higher TBR 
and cSUV values compared to the currently utilized protocol. We demonstrate that by delaying 
image acquisition to 3h new lesions, categorized as false-negative on the 1h PET, were now 
readily identified.  
By utilizing currently used imaging protocols with PET acquisition (1h post injection), the reader 
is often challenged to distinguish true coronary uptake from overspill from the surrounding 
structures. A large proportion of 18F-NaF positive plaques present with uptake which is at or only 
slightly higher than the background activity. Visualization of these lesion is usually possible 
because of below blood-pool activity in the adjacent myocardium. However, analysis can often 
be difficult particularly in the proximal and mid-LAD which lies close to blood pool in the 
pulmonary artery (Figure 1) and in the proximal circumflex that lies adjacent to the left atrial 
appendage. Techniques to improve the detection of such lesions are therefore required. To some 
extent blurring of the tracer uptake which occurs due to cardiorespiratory and patient motion can 
be mitigated with end-diastolic imaging, improving the conspicuousness of lesions (1). Recently 
developed cardiac motion correction techniques further improve image quality by co-registration 
of all cardiac gates to the reference one and allowing all PET data rather than that from a single 
diastolic gate to be utilized (15). In this study, we show that delaying 18F-NaF coronary image 
acquisition further facilitates assessment of coronary uptake, predominantly as a result of a 
decrease in the background blood pool activity.  
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Improved visual identification of the lesions on the delayed 18F-NaF PET acquisition is 
accompanied by significant improvements in TBR and corrected SUVmax measurements. While 
the coronary SUVmax remained unchanged on 3h PET imaging, the TBR values improved 
significantly. We observed an increase in the noise on delayed imaging (as expected due to a 
lower count statistic), however given the favorable decrease in the background (blood pool) 
activity, the noise level on 3h PET does not impede image analysis. 
The benefit of delayed PET acquisition for the detection of disease is widely appreciated in 
oncological applications with 18F-fluorodeoxyglucose (FDG)(20-24). There is good agreement 
that because background activity decreases on delayed imaging, the image quality improves. The 
lower background activity is a critical feature and advantage of delayed imaging, because it 
increases target to background ratios (25-26). It has been shown that a longer time window from 
injection to acquisition translates to higher signal to noise and therefore facilitates visual analysis 
providing higher diagnostic accuracy (20). For coronary PET imaging, it was suggested that the 
optimal timing for acquisition with FDG is 2.5-3h after tracer administration (27,28).  
In case of 18F-NaF PET bone imaging, since it has faster blood clearance and higher bone uptake 
compared to 99mTc-methylene diphosphonate, the SNM practice guideline recommends 
emission scanning for the axial skeleton as soon as 30-45 minutes after injection in patients with 
normal renal function (10) to decrease the overall time of the study. However, a longer waiting 
time of 90-120 minutes was recommended to acquire high-quality images of the extremities. 
Compared to uptake in the bony skeleton, 18F-NaF uptake due to active microcalcification 
formation in coronary plaque is very small in amount. Therefore, it is not surprising that a higher 
TBR in coronary plaques is observed with a longer waiting time from injection to acquisition. 
Longer delays for cardiovascular 18F-NaF PET imaging were evaluated by only one study to date 
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(14). Blomberg et al. concluded that delayed 18F-NaF PET imaging does not improve 
quantification of vascular calcification. However, the authors measured only overall heart 18F-
NaF activity (including blood pool) by placing regions of interest around the cardiac silhouette 
on ungated PET/CT images (excluding 18F-NaF activity originating from bones and cardiac 
valves), and averaged the SUV values derived from all slices. As a result, identifying additional 
foci of uptake on delayed imaging was not feasible. Moreover, that study was performed without 
cardiac gating and motion correction. Further, with 2.5-minute scan time and a 2.2 MBq dose of 
18F-NaF per kilogram of body weight the authors had approximately 16 times less counts 
compared to our coronary scans (~3.4MBq dose per kg and 30-min long acquisition).  
The utilization of coronary CT angiography in our study enabled measuring 18F-NaF uptake in 
individual coronary plaques. It also provided an opportunity to evaluate potential predictors of 
uptake by means of regression modelling (supplemental Tables S1 and S2). While our study is 
slightly underpowered such analysis revealed that TBR is positively associated with partially 
calcified plaque and inversely with lipid lowering drugs (statins). These findings are in line with 
previously published data showing that active calcification, macrophage infiltration and partially 
calcified plaques are associated with 18F-NaF uptake (2,29). On the contrary in our study 
completely calcified plaques did not attract the PET tracer which is in accordance with prior 
studies and supports the view that 18F-NaF is a marker active calcification including the stage 
before the development of advanced atherosclerotic lesions rather than established disease 
(30,31). Interestingly, as shown by the explanatory uni- and multivariate analysis the 
associations with clinical and imaging data are stronger when 3h PET measures rather 1h post 
injection PET values are utilized (Tables S1 and S2).  
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Our findings have important clinical implications. Given the challenges that 18F-NaF imaging 
faces, which include, but are not limited to small target lesion size, cardiac, respiratory and gross 
patient motion which collectively compromise image quality, a delayed acquisition protocol is an 
important step in mitigating the modest TBR reported in studies utilizing the 1h post injection 
protocol. By decreasing the background (blood pool) signal, not only do the TBR values 
improve, but also lesions which were difficult to detect 1h post injection can be easily identified. 
Additionally, by utilizing the 3 hours’ post injection approach coronary uptake can be more 
readily assessed by less experienced readers. In our view, such a protocol can facilitate 
dissemination of this imaging techniques beyond academic institutions.  
  
Limitations 
We acknowledge that our study was based on a modest number of patients with stable CAD. 
Importantly, despite this limitation our findings are supported by statistically significant data. 
The normal limits applied to define an increase in TBR values in our population were based on 
those derived from 1h data; thus, it is likely that reference values for relevant uptake on 3h 18F-
NaF coronary PET will need to be derived for optimal use of delayed imaging (1,2). The 
utilization of TBR as a measure of tracer uptake remains to some degree controversial (32); 
however, we also evaluated corrected SUVmax measurements which have been suggested to be 
more robust for coronary imaging. The low TBR values in our study can be attributed to partial 
volume effects as adjacent myocardium presents on average with 60% of the blood-pool uptake 
(33). We acknowledge that a 3h post injection PET protocol may lead to reorganizing the 
workflow within the nuclear medicine imaging facility and will prolong the time patients spend 
in the imaging facility. Nevertheless, the benefits of delayed PET acquisition for the assessment 
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of 18F-NaF coronary uptake undoubtedly outweigh the aforementioned workflow 
inconveniences.   
Conclusions 
Blood-pool activity decreases on delayed imaging facilitating the assessment of 18F-NaF uptake 
in coronary plaques. It increases the corrected SUVmax and target to background ratios on 
average by 92% (range: 33-225%) and 80% (range: 20-177%), leading to the detection of more 
plaques with clear increases in uptake compared to the standard 1h protocol. A greater than a 1h 
delay may improve the detection of 18F-NaF uptake in coronary artery plaques. 
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Tables: 
Table 1. Patients’ baseline clinical characteristics.  
 Study cohort 
(n=20) 
SD, IQR, % 
Baseline Characteristics 
Age, years 67 ±7 
Males, n (%) 11 (55%) 
Diabetes, n (%) 4 (20%) 
Hyperlipidemia, n (%) 5 (25%) 
Hypertension, n (%) 12 (60%) 
Tobacco use, n (%) 6 (30%) 
Family history of CAD, n (%) 3 (15%) 
Serum Biomarkers 
Total Cholesterol 162 [135-189] 
HDL 43 [38-46] 
LDL 93 [71-107] 
Triglyceride 121 [86-140] 
Creatine 0.8 [0.7-0.9] 
Medications 
Aspirin, n (%) 13 (65%) 
Statin, n (%) 6 (30%) 
ACEI/ARB, n (%) 6 (30%) 
Beta Blocker, n (%) 7 (35%) 
Leading clinical indication for CTA 
Chest pain, n (%) 15 (75%) 
Dyspnea, n (%) 3 (15%) 
Risk assessment (asymptomatic 
patient), n (%) 
2 (10%) 
 23 
Coronary Computed Tomography Angiography  
Segment involvement score 6 [3-8] 
Multivessel disease, n (%) 6 (30%) 
Coronary calcium score 312 [50-770] 
 
 
CAD: coronary artery disease; CTA: coronary computed tomography angiography; HDL – high 
density lipoprotein; LDL – low density lipoprotein; ACEI – angiotensin converting enzyme 
inhibitor; ARB – angiotensin receptor blocker; SD – standard deviation; IQR - Interquartile 
range. 
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Table 2.  Comparison of 18F-NaF motion corrected measurements on 1h and 3h post injection 
PET imaging. 
 1-hour post 
injection PET 
3-hour post injection 
PET 
P Value 
SUVmax 1.55 [1.43-1.89] 1.63 [1.37-1.98] 0.30 
TBR 1.28 [0.98-1.56] 2.30 [1.70-2.68] <0.001 
Corrected SUVmax 0.38 [0.27-0.70] 0.90 [0.64-1.17] <0.001 
Background (blood pool) 1.24 [1.05-1.31] 0.71 [0.65-0.81] <0.001 
Noise 0.07 [0.06-0.09] 0.10 [0.09-0.12] 0.02 
Segments with TBR>1.25, n (%) 26 (8%) 33 (10%) 0.01 
Patients with TBR>1.25, n (%) 12 (60%) 15 (75%) 0.004 
 
18F-NaF: 18F-sodium fluoride; PET: positron emission tomography; SUVmax: maximum 
standard uptake values; TBR: maximum target to background ratios. 
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FIGURE 1. Assessment of 18F-NaF coronary uptake on 1h and 3h delayed PET.  
Four patients with significant (TBR>1.25) on 1h post injection (left column) coronary uptake in 
the left anterior descending artery. Uptake can be difficult to differentiate in this region from 
blood pool in the adjacent pulmonary artery. On 3h PET (right column) the TBR increased 
significantly, and blood pool activity reduced improving image quality. 
  
18F-NaF: 18F-sodium fluoride; PET: positron emission tomography; TBR: target to background 
ratios; SUV: standard uptake value 
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FIGURE 2. Examples of coronary plaques with significant uptake on 3h PET and low 
tracer activity of 1h post injection imaging.  
Short axis images of proximal left anterior descending, proximal circumflex (A) and distal right 
coronary artery (B) plaques which had a TBR<1.0 on 1h PET (left column) and showed uptake 
exceeding the 1.25 TBR threshold at 3h
 
TBR: target to background ratios; PET: positron emission tomography 
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FIGURE 3. 18F-NaF coronary uptake measures on 1h and 3h delayed PET.  
Maximum standard uptake values (SUVmax) values were comparable on both scans (A). The 
corrected SUVmax and target to background (TBR) values were higher on 3h post injection PET 
(B,C). The background (right atrium blood pool SUVmean) was lower on 3h imaging (D). 
 
 
PET: positron emission tomography; 18F-NaF: 18F-sodium fluoride 
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Figure 4 Line-plots of 18F-NaF coronary uptake measurements on 1h and 3h delayed PET. 
Maximum standard uptake values (SUVmax) values were comparable on both scans (A). The 
corrected SUVmax and target to background (TBR) values were higher on 3h post injection PET 
(B,C). The background (right atrium blood pool SUVmean) was lower on 3h imaging (D). 
 
PET: positron emission tomography; 18F-NaF: 18F-sodium fluoride 
 




